[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Antithrombin Market Growth 2022-2028

February 2022 | 90 pages | ID: GD3951E829EEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Antithrombin will have significant change from previous year. According to our (LP Information) latest study, the global Antithrombin market size is USD million in 2022 from USD 501.6 million in 2021, with a change of % between 2021 and 2022. The global Antithrombin market size will reach USD 680.3 million in 2028, growing at a CAGR of 4.5% over the analysis period.

The United States Antithrombin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Antithrombin market, reaching US$ million by the year 2028. As for the Europe Antithrombin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Antithrombin players cover Grifols, rEVO Biologics Inc., Takeda, and Kedrion S.p.A., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Antithrombin market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
  • Liquid
  • Lyophilized
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
  • Diagnostics
  • Therapeutics
  • Research
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
  • Grifols
  • rEVO Biologics Inc.
  • Takeda
  • Kedrion S.p.A.
  • CSL Limited
  • Scripps Laboratories Inc.
  • Lee Biosolutions
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Antithrombin Annual Sales 2017-2028
  2.1.2 World Current & Future Analysis for Antithrombin by Geographic Region, 2017, 2022 & 2028
  2.1.3 World Current & Future Analysis for Antithrombin by Country/Region, 2017, 2022 & 2028
2.2 Antithrombin Segment by Type
  2.2.1 Liquid
  2.2.2 Lyophilized
2.3 Antithrombin Sales by Type
  2.3.1 Global Antithrombin Sales Market Share by Type (2017-2022)
  2.3.2 Global Antithrombin Revenue and Market Share by Type (2017-2022)
  2.3.3 Global Antithrombin Sale Price by Type (2017-2022)
2.4 Antithrombin Segment by Application
  2.4.1 Diagnostics
  2.4.2 Therapeutics
  2.4.3 Research
2.5 Antithrombin Sales by Application
  2.5.1 Global Antithrombin Sale Market Share by Application (2017-2022)
  2.5.2 Global Antithrombin Revenue and Market Share by Application (2017-2022)
  2.5.3 Global Antithrombin Sale Price by Application (2017-2022)

3 GLOBAL ANTITHROMBIN BY COMPANY

3.1 Global Antithrombin Breakdown Data by Company
  3.1.1 Global Antithrombin Annual Sales by Company (2020-2022)
  3.1.2 Global Antithrombin Sales Market Share by Company (2020-2022)
3.2 Global Antithrombin Annual Revenue by Company (2020-2022)
  3.2.1 Global Antithrombin Revenue by Company (2020-2022)
  3.2.2 Global Antithrombin Revenue Market Share by Company (2020-2022)
3.3 Global Antithrombin Sale Price by Company
3.4 Key Manufacturers Antithrombin Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Antithrombin Product Location Distribution
  3.4.2 Players Antithrombin Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR ANTITHROMBIN BY GEOGRAPHIC REGION

4.1 World Historic Antithrombin Market Size by Geographic Region (2017-2022)
  4.1.1 Global Antithrombin Annual Sales by Geographic Region (2017-2022)
  4.1.2 Global Antithrombin Annual Revenue by Geographic Region
4.2 World Historic Antithrombin Market Size by Country/Region (2017-2022)
  4.2.1 Global Antithrombin Annual Sales by Country/Region (2017-2022)
  4.2.2 Global Antithrombin Annual Revenue by Country/Region
4.3 Americas Antithrombin Sales Growth
4.4 APAC Antithrombin Sales Growth
4.5 Europe Antithrombin Sales Growth
4.6 Middle East & Africa Antithrombin Sales Growth

5 AMERICAS

5.1 Americas Antithrombin Sales by Country
  5.1.1 Americas Antithrombin Sales by Country (2017-2022)
  5.1.2 Americas Antithrombin Revenue by Country (2017-2022)
5.2 Americas Antithrombin Sales by Type
5.3 Americas Antithrombin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Antithrombin Sales by Region
  6.1.1 APAC Antithrombin Sales by Region (2017-2022)
  6.1.2 APAC Antithrombin Revenue by Region (2017-2022)
6.2 APAC Antithrombin Sales by Type
6.3 APAC Antithrombin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Antithrombin by Country
  7.1.1 Europe Antithrombin Sales by Country (2017-2022)
  7.1.2 Europe Antithrombin Revenue by Country (2017-2022)
7.2 Europe Antithrombin Sales by Type
7.3 Europe Antithrombin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Antithrombin by Country
  8.1.1 Middle East & Africa Antithrombin Sales by Country (2017-2022)
  8.1.2 Middle East & Africa Antithrombin Revenue by Country (2017-2022)
8.2 Middle East & Africa Antithrombin Sales by Type
8.3 Middle East & Africa Antithrombin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antithrombin
10.3 Manufacturing Process Analysis of Antithrombin
10.4 Industry Chain Structure of Antithrombin

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Antithrombin Distributors
11.3 Antithrombin Customer

12 WORLD FORECAST REVIEW FOR ANTITHROMBIN BY GEOGRAPHIC REGION

12.1 Global Antithrombin Market Size Forecast by Region
  12.1.1 Global Antithrombin Forecast by Region (2023-2028)
  12.1.2 Global Antithrombin Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Antithrombin Forecast by Type
12.7 Global Antithrombin Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Grifols
  13.1.1 Grifols Company Information
  13.1.2 Grifols Antithrombin Product Offered
  13.1.3 Grifols Antithrombin Sales, Revenue, Price and Gross Margin (2020-2022)
  13.1.4 Grifols Main Business Overview
  13.1.5 Grifols Latest Developments
13.2 rEVO Biologics Inc.
  13.2.1 rEVO Biologics Inc. Company Information
  13.2.2 rEVO Biologics Inc. Antithrombin Product Offered
  13.2.3 rEVO Biologics Inc. Antithrombin Sales, Revenue, Price and Gross Margin (2020-2022)
  13.2.4 rEVO Biologics Inc. Main Business Overview
  13.2.5 rEVO Biologics Inc. Latest Developments
13.3 Takeda
  13.3.1 Takeda Company Information
  13.3.2 Takeda Antithrombin Product Offered
  13.3.3 Takeda Antithrombin Sales, Revenue, Price and Gross Margin (2020-2022)
  13.3.4 Takeda Main Business Overview
  13.3.5 Takeda Latest Developments
13.4 Kedrion S.p.A.
  13.4.1 Kedrion S.p.A. Company Information
  13.4.2 Kedrion S.p.A. Antithrombin Product Offered
  13.4.3 Kedrion S.p.A. Antithrombin Sales, Revenue, Price and Gross Margin (2020-2022)
  13.4.4 Kedrion S.p.A. Main Business Overview
  13.4.5 Kedrion S.p.A. Latest Developments
13.5 CSL Limited
  13.5.1 CSL Limited Company Information
  13.5.2 CSL Limited Antithrombin Product Offered
  13.5.3 CSL Limited Antithrombin Sales, Revenue, Price and Gross Margin (2020-2022)
  13.5.4 CSL Limited Main Business Overview
  13.5.5 CSL Limited Latest Developments
13.6 Scripps Laboratories Inc.
  13.6.1 Scripps Laboratories Inc. Company Information
  13.6.2 Scripps Laboratories Inc. Antithrombin Product Offered
  13.6.3 Scripps Laboratories Inc. Antithrombin Sales, Revenue, Price and Gross Margin (2020-2022)
  13.6.4 Scripps Laboratories Inc. Main Business Overview
  13.6.5 Scripps Laboratories Inc. Latest Developments
13.7 Lee Biosolutions
  13.7.1 Lee Biosolutions Company Information
  13.7.2 Lee Biosolutions Antithrombin Product Offered
  13.7.3 Lee Biosolutions Antithrombin Sales, Revenue, Price and Gross Margin (2020-2022)
  13.7.4 Lee Biosolutions Main Business Overview
  13.7.5 Lee Biosolutions Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Antithrombin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Antithrombin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Liquid
Table 4. Major Players of Lyophilized
Table 5. Global Antithrombin Sales by Type (2017-2022) & (Units)
Table 6. Global Antithrombin Sales Market Share by Type (2017-2022)
Table 7. Global Antithrombin Revenue by Type (2017-2022) & ($ million)
Table 8. Global Antithrombin Revenue Market Share by Type (2017-2022)
Table 9. Global Antithrombin Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Antithrombin Sales by Application (2017-2022) & (Units)
Table 11. Global Antithrombin Sales Market Share by Application (2017-2022)
Table 12. Global Antithrombin Revenue by Application (2017-2022)
Table 13. Global Antithrombin Revenue Market Share by Application (2017-2022)
Table 14. Global Antithrombin Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Antithrombin Sales by Company (2020-2022) & (Units)
Table 16. Global Antithrombin Sales Market Share by Company (2020-2022)
Table 17. Global Antithrombin Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Antithrombin Revenue Market Share by Company (2020-2022)
Table 19. Global Antithrombin Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Antithrombin Producing Area Distribution and Sales Area
Table 21. Players Antithrombin Products Offered
Table 22. Antithrombin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Antithrombin Sales by Geographic Region (2017-2022) & (Units)
Table 26. Global Antithrombin Sales Market Share Geographic Region (2017-2022)
Table 27. Global Antithrombin Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Antithrombin Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Antithrombin Sales by Country/Region (2017-2022) & (Units)
Table 30. Global Antithrombin Sales Market Share by Country/Region (2017-2022)
Table 31. Global Antithrombin Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Antithrombin Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Antithrombin Sales by Country (2017-2022) & (Units)
Table 34. Americas Antithrombin Sales Market Share by Country (2017-2022)
Table 35. Americas Antithrombin Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Antithrombin Revenue Market Share by Country (2017-2022)
Table 37. Americas Antithrombin Sales by Type (2017-2022) & (Units)
Table 38. Americas Antithrombin Sales Market Share by Type (2017-2022)
Table 39. Americas Antithrombin Sales by Application (2017-2022) & (Units)
Table 40. Americas Antithrombin Sales Market Share by Application (2017-2022)
Table 41. APAC Antithrombin Sales by Region (2017-2022) & (Units)
Table 42. APAC Antithrombin Sales Market Share by Region (2017-2022)
Table 43. APAC Antithrombin Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Antithrombin Revenue Market Share by Region (2017-2022)
Table 45. APAC Antithrombin Sales by Type (2017-2022) & (Units)
Table 46. APAC Antithrombin Sales Market Share by Type (2017-2022)
Table 47. APAC Antithrombin Sales by Application (2017-2022) & (Units)
Table 48. APAC Antithrombin Sales Market Share by Application (2017-2022)
Table 49. Europe Antithrombin Sales by Country (2017-2022) & (Units)
Table 50. Europe Antithrombin Sales Market Share by Country (2017-2022)
Table 51. Europe Antithrombin Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Antithrombin Revenue Market Share by Country (2017-2022)
Table 53. Europe Antithrombin Sales by Type (2017-2022) & (Units)
Table 54. Europe Antithrombin Sales Market Share by Type (2017-2022)
Table 55. Europe Antithrombin Sales by Application (2017-2022) & (Units)
Table 56. Europe Antithrombin Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Antithrombin Sales by Country (2017-2022) & (Units)
Table 58. Middle East & Africa Antithrombin Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Antithrombin Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Antithrombin Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Antithrombin Sales by Type (2017-2022) & (Units)
Table 62. Middle East & Africa Antithrombin Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Antithrombin Sales by Application (2017-2022) & (Units)
Table 64. Middle East & Africa Antithrombin Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Antithrombin
Table 66. Key Market Challenges & Risks of Antithrombin
Table 67. Key Industry Trends of Antithrombin
Table 68. Antithrombin Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Antithrombin Distributors List
Table 71. Antithrombin Customer List
Table 72. Global Antithrombin Sales Forecast by Region (2023-2028) & (Units)
Table 73. Global Antithrombin Sales Market Forecast by Region
Table 74. Global Antithrombin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Antithrombin Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Antithrombin Sales Forecast by Country (2023-2028) & (Units)
Table 77. Americas Antithrombin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Antithrombin Sales Forecast by Region (2023-2028) & (Units)
Table 79. APAC Antithrombin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Antithrombin Sales Forecast by Country (2023-2028) & (Units)
Table 81. Europe Antithrombin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Antithrombin Sales Forecast by Country (2023-2028) & (Units)
Table 83. Middle East & Africa Antithrombin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Antithrombin Sales Forecast by Type (2023-2028) & (Units)
Table 85. Global Antithrombin Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Antithrombin Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Antithrombin Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Antithrombin Sales Forecast by Application (2023-2028) & (Units)
Table 89. Global Antithrombin Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Antithrombin Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Antithrombin Revenue Market Share Forecast by Application (2023-2028)
Table 92. Grifols Basic Information, Antithrombin Manufacturing Base, Sales Area and Its Competitors
Table 93. Grifols Antithrombin Product Offered
Table 94. Grifols Antithrombin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Grifols Main Business
Table 96. Grifols Latest Developments
Table 97. rEVO Biologics Inc. Basic Information, Antithrombin Manufacturing Base, Sales Area and Its Competitors
Table 98. rEVO Biologics Inc. Antithrombin Product Offered
Table 99. rEVO Biologics Inc. Antithrombin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. rEVO Biologics Inc. Main Business
Table 101. rEVO Biologics Inc. Latest Developments
Table 102. Takeda Basic Information, Antithrombin Manufacturing Base, Sales Area and Its Competitors
Table 103. Takeda Antithrombin Product Offered
Table 104. Takeda Antithrombin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Takeda Main Business
Table 106. Takeda Latest Developments
Table 107. Kedrion S.p.A. Basic Information, Antithrombin Manufacturing Base, Sales Area and Its Competitors
Table 108. Kedrion S.p.A. Antithrombin Product Offered
Table 109. Kedrion S.p.A. Antithrombin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Kedrion S.p.A. Main Business
Table 111. Kedrion S.p.A. Latest Developments
Table 112. CSL Limited Basic Information, Antithrombin Manufacturing Base, Sales Area and Its Competitors
Table 113. CSL Limited Antithrombin Product Offered
Table 114. CSL Limited Antithrombin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. CSL Limited Main Business
Table 116. CSL Limited Latest Developments
Table 117. Scripps Laboratories Inc. Basic Information, Antithrombin Manufacturing Base, Sales Area and Its Competitors
Table 118. Scripps Laboratories Inc. Antithrombin Product Offered
Table 119. Scripps Laboratories Inc. Antithrombin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Scripps Laboratories Inc. Main Business
Table 121. Scripps Laboratories Inc. Latest Developments
Table 122. Lee Biosolutions Basic Information, Antithrombin Manufacturing Base, Sales Area and Its Competitors
Table 123. Lee Biosolutions Antithrombin Product Offered
Table 124. Lee Biosolutions Antithrombin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Lee Biosolutions Main Business
Table 126. Lee Biosolutions Latest Developments

LIST OF FIGURES

Figure 1. Picture of Antithrombin
Figure 2. Antithrombin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antithrombin Sales Growth Rate 2017-2028 (Units)
Figure 7. Global Antithrombin Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Antithrombin Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Liquid
Figure 10. Product Picture of Lyophilized
Figure 11. Global Antithrombin Sales Market Share by Type in 2021
Figure 12. Global Antithrombin Revenue Market Share by Type (2017-2022)
Figure 13. Antithrombin Consumed in Diagnostics
Figure 14. Global Antithrombin Market: Diagnostics (2017-2022) & (Units)
Figure 15. Antithrombin Consumed in Therapeutics
Figure 16. Global Antithrombin Market: Therapeutics (2017-2022) & (Units)
Figure 17. Antithrombin Consumed in Research
Figure 18. Global Antithrombin Market: Research (2017-2022) & (Units)
Figure 19. Global Antithrombin Sales Market Share by Application (2017-2022)
Figure 20. Global Antithrombin Revenue Market Share by Application in 2021
Figure 21. Antithrombin Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Antithrombin Revenue Market Share by Company in 2021
Figure 23. Global Antithrombin Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Antithrombin Revenue Market Share by Geographic Region in 2021
Figure 25. Global Antithrombin Sales Market Share by Region (2017-2022)
Figure 26. Global Antithrombin Revenue Market Share by Country/Region in 2021
Figure 27. Americas Antithrombin Sales 2017-2022 (Units)
Figure 28. Americas Antithrombin Revenue 2017-2022 ($ Millions)
Figure 29. APAC Antithrombin Sales 2017-2022 (Units)
Figure 30. APAC Antithrombin Revenue 2017-2022 ($ Millions)
Figure 31. Europe Antithrombin Sales 2017-2022 (Units)
Figure 32. Europe Antithrombin Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Antithrombin Sales 2017-2022 (Units)
Figure 34. Middle East & Africa Antithrombin Revenue 2017-2022 ($ Millions)
Figure 35. Americas Antithrombin Sales Market Share by Country in 2021
Figure 36. Americas Antithrombin Revenue Market Share by Country in 2021
Figure 37. United States Antithrombin Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Antithrombin Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Antithrombin Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Antithrombin Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Antithrombin Sales Market Share by Region in 2021
Figure 42. APAC Antithrombin Revenue Market Share by Regions in 2021
Figure 43. China Antithrombin Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Antithrombin Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Antithrombin Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Antithrombin Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Antithrombin Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Antithrombin Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Antithrombin Sales Market Share by Country in 2021
Figure 50. Europe Antithrombin Revenue Market Share by Country in 2021
Figure 51. Germany Antithrombin Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Antithrombin Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Antithrombin Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Antithrombin Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Antithrombin Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Antithrombin Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Antithrombin Revenue Market Share by Country in 2021
Figure 58. Egypt Antithrombin Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Antithrombin Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Antithrombin Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Antithrombin Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Antithrombin Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Antithrombin in 2021
Figure 64. Manufacturing Process Analysis of Antithrombin
Figure 65. Industry Chain Structure of Antithrombin
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles


More Publications